Showing results (51-60 of 99) with videos related to
Sort By:
Pageof 10
Intestinal Research|February 7, 2022
Vedolizumab for perianal fistulizing Crohn's disease: systematic review and meta-analysisFares Ayoub, Matthew Odenwald, Dejan Micic, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 30, 2021
External Validation and Comparison of Clostridioides difficile Severity Scoring SystemsD Alexander Perry, Daniel Shirley, Dejan Micic, et al.Plos One|February 21, 2019
Risk factors for small bowel bleeding in an overt gastrointestinal bleeding presentation after negative upper and lower endoscopyDejan Micic, John N Gaetano, Neha Nigam, et al.Gut Pathogens|August 30, 2022
Clostridioides difficile toxin is infrequently detected in inflammatory bowel disease and does not associate with clinical outcomesRachel Bernard, Muhammad B Hammami, Forest W Arnold, et al.Journal of the American Geriatrics Society|October 3, 2013
Poor functional status as a risk factor for severe Clostridium difficile infection in hospitalized older adultsKrishna Rao, Dejan Micic, Elizabeth Chenoweth, et al.Inflammatory Bowel Diseases|December 15, 2020
Inpatient Therapy With Calcineurin Inhibitors in Severe Ulcerative ColitisSujaata Dwadasi, Maryam Zafer, Donald Goens, et al.International Journal of Colorectal Disease|July 26, 2020
Efficacy of biosimilar infliximab CT-P13 among inpatients with severe steroid-refractory colitisJacob E Ollech, Inessa Normatov, Noam Peleg, et al.Annals of Surgical Oncology|May 6, 2021
Guide to Enhanced Recovery for Cancer Patients Undergoing Surgery: ERAS for Patients Undergoing Cytoreductive Surgery with or Without HIPECAnkit Dhiman, Emily Fenton, Jeffrey Whitridge, et al.Digestive Diseases and Sciences|July 5, 2022
Serum Cytomegalovirus Polymerase Chain Reaction Test Is a Valuable Negative Predictor of Infection in Acute Severe Ulcerative ColitisNathaniel A Cohen, Maryam Zafer, Namrata Setia, et al.Inflammatory Bowel Diseases|March 22, 2018
Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and SafetyBritt Christensen, Ruben J Colman, Dejan Micic, et al.Pageof 10